These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 3100000)

  • 1. Effect of 1 alpha-hydroxycholecalciferol on psoriasis vulgaris: a pilot study.
    Takamoto S; Onishi T; Morimoto S; Imanaka S; Yukawa S; Kozuka T; Kitano Y; Seino Y; Kumahara Y
    Calcif Tissue Int; 1986 Dec; 39(6):360-4. PubMed ID: 3100000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of psoriasis vulgaris by oral administration of 1 alpha-hydroxyvitamin D3--open-design study.
    Morimoto S; Yoshikawa K; Kozuka T; Kitano Y; Imanaka S; Fukuo K; Koh E; Onishi T; Kumahara Y
    Calcif Tissue Int; 1986 Sep; 39(3):209-12. PubMed ID: 3093033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An open study of vitamin D3 treatment in psoriasis vulgaris.
    Morimoto S; Yoshikawa K; Kozuka T; Kitano Y; Imanaka S; Fukuo K; Koh E; Kumahara Y
    Br J Dermatol; 1986 Oct; 115(4):421-9. PubMed ID: 3022784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of vitamin D3 derivatives in the treatment of psoriasis vulgaris: a preliminary report.
    el-Azhary RA; Peters MS; Pittelkow MR; Kao PC; Muller SA
    Mayo Clin Proc; 1993 Sep; 68(9):835-41. PubMed ID: 8396699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A trial of the Actiderm dermatological patch and topical corticosteroids in the treatment of psoriasis vulgaris. The Actiderm Multi-Center Study Group.
    Cutis; 1990 Jul; 46(1):84-8. PubMed ID: 2200652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical corticosteroids in plaque psoriasis: a systematic review of efficacy and treatment modalities.
    Castela E; Archier E; Devaux S; Gallini A; Aractingi S; Cribier B; Jullien D; Aubin F; Bachelez H; Joly P; Le Maître M; Misery L; Richard MA; Paul C; Ortonne JP
    J Eur Acad Dermatol Venereol; 2012 May; 26 Suppl 3():36-46. PubMed ID: 22512679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral PSORI-CM01, a Chinese herbal formula, plus topical sequential therapy for moderate-to-severe psoriasis vulgaris: pilot study for a double-blind, randomized, placebo-controlled trial.
    Yao DN; Lu CJ; Wen ZH; Yan YH; Xuan ML; Li XY; Li G; He ZH; Xie XL; Deng JW; Guo XF; Ou AH
    Trials; 2016 Mar; 17(1):140. PubMed ID: 26983642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidermal keratin levels during oral 1-alpha-hydroxyvitamin D3 treatment for psoriasis.
    Holland DB; Wood EJ; Roberts SG; West MR; Cunliffe WJ
    Skin Pharmacol; 1989; 2(2):68-76. PubMed ID: 2483330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical management of psoriasis - corticosteroids and sparing corticosteroid therapy.
    Gorgievska Sukarovska B; Lipozencić J
    Acta Dermatovenerol Croat; 2006; 14(3):188-96. PubMed ID: 17010269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors impacting the combination of topical corticosteroid therapies for psoriasis: perspectives from the International Psoriasis Council.
    van de Kerkhof PC; Kragballe K; Segaert S; Lebwohl M;
    J Eur Acad Dermatol Venereol; 2011 Oct; 25(10):1130-9. PubMed ID: 21564329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psoriasis and vitamin D3. A review of our experience.
    Morimoto S; Yoshikawa K
    Arch Dermatol; 1989 Feb; 125(2):231-4. PubMed ID: 2536537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of scalp psoriasis: guidelines for corticosteroid use in combination treatment.
    van der Vleuten CJ; van de Kerkhof PC
    Drugs; 2001; 61(11):1593-8. PubMed ID: 11577796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement in aspects of sleep with etanercept and optional adjunctive topical therapy in patients with moderate-to-severe psoriasis: results from the PRISTINE trial.
    Thaçi D; Galimberti R; Amaya-Guerra M; Rosenbach T; Robertson D; Pedersen R; Yang S; Kuligowski M; Boggs R
    J Eur Acad Dermatol Venereol; 2014 Jul; 28(7):900-6. PubMed ID: 23848989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical corticosteroids in psoriasis: strategies for improving safety.
    Horn EJ; Domm S; Katz HI; Lebwohl M; Mrowietz U; Kragballe K;
    J Eur Acad Dermatol Venereol; 2010 Feb; 24(2):119-24. PubMed ID: 20175860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical administration of 1,25-dihydroxyvitamin D3 for psoriasis: report of five cases.
    Morimoto S; Onishi T; Imanaka S; Yukawa H; Kozuka T; Kitano Y; Yoshikawa K; Kumahara Y
    Calcif Tissue Int; 1986 Feb; 38(2):119-22. PubMed ID: 3082494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corticosteroids.
    Hughes J; Rustin M
    Clin Dermatol; 1997; 15(5):715-21. PubMed ID: 9313970
    [No Abstract]   [Full Text] [Related]  

  • 17. Short-term effects of 1-alpha-hydroxy-vitamin D3 in patients on corticosteroid treatment and in patients with senile osteoporosis.
    Lindgren U; Lindholm S; Sarby B
    Acta Med Scand; 1978; 204(1-2):89-92. PubMed ID: 685736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral granulated Chinese herbal medicine (YXBCM01) plus topical calcipotriol for psoriasis vulgaris: study protocol for a double-blind, randomized placebo controlled trial.
    Parker S; Zhang AL; Zhang CS; Goodman G; Wen Z; Lu C; Xue CC
    Trials; 2014 Dec; 15():495. PubMed ID: 25526951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Local treatments of cutaneous psoriasis].
    Enjolras O
    Rev Prat; 1991 Oct; 41(22):2174-6. PubMed ID: 1784918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of 25-hydroxycholecalciferol on bone lesions of children with terminal renal failure.
    Witmer G; Margolis A; Fontaine O; Fritsch J; Lenoir G; Broyer M; Balsan S
    Kidney Int; 1976 Nov; 10(5):395-408. PubMed ID: 794558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.